Gilead Sciences Inc (GILD) earnings · rev $29.44B
These earnings events as JSON? API free 100/dayGilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
This GILD earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B.
When the next GILD 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 2.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full GILD research stays on the stock page; the tape stays on the quote page.
GILD earnings FAQ
What are GILD's latest revenue and net income?
Latest cached Gilead Sciences Inc (GILD) revenue for Dec 31, 2025 was $29.44B. Net income was $8.51B. Statements: https://lician.com/financials/gild
What is GILD's latest diluted EPS?
Latest cached Gilead Sciences Inc (GILD) diluted EPS for Dec 31, 2025 was $6.78.
What period does the latest GILD earnings print cover?
The latest cached Gilead Sciences Inc (GILD) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did GILD revenue change from the prior cached period?
Cached Gilead Sciences Inc (GILD) revenue was up 2.4% from $28.75B (Dec 31, 2024) to $29.44B (Dec 31, 2025). Statements: https://lician.com/financials/gild
Where are GILD earnings listed?
Cached earnings facts for Gilead Sciences Inc (GILD) are listed at https://lician.com/earnings/gild. Statements: https://lician.com/financials/gild
Not investment advice.